CSGALNACT2 and ovarian cancer: KEGG pathway analysis demonstrated that the expression of CSGALNACT2 in ovarian cancer was correlated with the MAPK signaling pathway, Lipid and atherosclerosis, and Cell cycle, and the highest correlation was with the MAPK signaling pathway (Fig. 5G and H, Supplementary Table 1).